Spren offers a camera-enabled biomarker platform that measures health indicators through an app.
Founded in 2017 and based in Asheville, Spren provides a camera-enabled biomarker platform with machine learning insights on heart rate variability, body composition, stress, recovery, and progress. Its tools are available through an SDK and API. In October 2022, the company raised USD 11.3 million in seed funding led by DRIVE by DraftKings, with participation from Boston Seed Capital, Karlani Capital, and Permit Ventures. It planned to expand its enterprise platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in